US Patent 10117945 mTORC1 inhibitors

Is a

Patent

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

10117945

Patent Inventor Names

Kevan Shokat0

Masanori Okaniwa0

Date of Patent

November 6, 2018

Patent Application Number

15455727

Date Filed

March 10, 2017

Patent Citations Received

‌

US Patent 12121522 Methods of treating cancer with an mTOR inhibitor

‌

US Patent 10980889 C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitors

‌

US Patent 11685749 C26-linked rapamycin analogs as mTOR inhibitors

‌

US Patent 11364300 C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitors

‌

US Patent 11819476 Rapamycin analogs and uses thereof

‌

US Patent 10646577 mTORC1 inhibitors

‌

US Patent 10683308 Rapamycin analogs and uses thereof

Patent Primary Examiner

‌

Bruck Kifle

Patent abstract

Disclosed herein, inter alia, are compounds and methods of using the same for modulating the activity of mTORC1.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 10117945 mTORC1 inhibitors

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 10117945 mTORC1 inhibitors